Anti-inflammatory Medications for Patients with Cardiac Stents
Safe Anti-inflammatory Options
- The American Heart Association recommends acetaminophen as the safest first-line anti-inflammatory option for patients with cardiac stents, as it has no significant cardiovascular effects 1
- The American College of Cardiology suggests that nonselective NSAIDs should be avoided whenever possible in patients with cardiac stents due to increased risk of adverse cardiovascular events 2
Risk Stratification and Recommendations
- For patients with mild pain, the European Society of Cardiology recommends using acetaminophen as first-line therapy at recommended doses 1
- For patients with moderate pain unresponsive to acetaminophen, the European Heart Journal suggests adding a proton pump inhibitor for gastrointestinal protection when using naproxen at the lowest effective dose for the shortest duration possible 3, 4
- The American Heart Association recommends that for post-operative or acute severe pain, short-term use of opioid medications may be safer than NSAIDs from a cardiovascular perspective 1
Important Considerations
- The European Heart Journal notes that patients with cardiac stents are typically on aspirin and/or P2Y12 inhibitors, which increases bleeding risk when combined with NSAIDs 3, 5
Management of Pain in Post-PCI Patients
Dual Antiplatelet Therapy and NSAID Interaction
- The American College of Cardiology guidelines recommend that patients after PCI remain on dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor for at least 12 months, and adding an NSAID to DAPT dramatically increases bleeding risk while simultaneously increasing thrombotic risk 6, 7, 8
- The American College of Cardiology guidelines note that use of PPIs is reasonable in patients with increased risk of GI bleeding (including concomitant use of NSAIDs) who require DAPT, with a recommendation for PPI therapy to reduce GI bleeding risk 6, 8